BIRC3 and B-cell chronic lymphocytic leukemia: In contrast to overexpression in some tumor types, BIRC3 is sometimes deleted or mutated in chronic lymphocytic leukemia (CLL) and other lymphoid malignancies, and alterations in BIRC3 have also been associated with treatment resistance29–35.